vs
FONAR CORP（FONR）与RIVERVIEW BANCORP INC（RVSB）财务数据对比。点击上方公司名可切换其他公司
FONAR CORP的季度营收约是RIVERVIEW BANCORP INC的1.8倍（$25.5M vs $14.0M），RIVERVIEW BANCORP INC净利率更高（9.8% vs 8.0%，领先1.8%），RIVERVIEW BANCORP INC同比增速更快（10.4% vs 2.4%），FONAR CORP自由现金流更多（$-227.0K vs $-736.0K），过去两年RIVERVIEW BANCORP INC的营收复合增速更高（24.6% vs -0.3%）
FONAR是一家专业医疗技术企业，专注于设计、制造及销售包括立式、开放式在内的创新磁共振成像（MRI）设备，主要服务美国的医院、影像诊断中心及医疗机构，为临床诊断提供高精度扫描解决方案。
Riverview Bancorp Inc.是一家总部位于美国的银行控股公司，主营个人与商业银行业务，服务覆盖太平洋西北地区，提供存款、消费贷款、住房抵押贷款、商业信贷及小企业金融等产品，服务零售客户与本地企业群体。
FONR vs RVSB — 直观对比
营收规模更大
FONR
是对方的1.8倍
$14.0M
营收增速更快
RVSB
高出8.0%
2.4%
净利率更高
RVSB
高出1.8%
8.0%
自由现金流更多
FONR
多$509.0K
$-736.0K
两年增速更快
RVSB
近两年复合增速
-0.3%
损益表 — Q2 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $25.5M | $14.0M |
| 净利润 | $2.1M | $1.4M |
| 毛利率 | — | — |
| 营业利润率 | 13.5% | 12.4% |
| 净利率 | 8.0% | 9.8% |
| 营收同比 | 2.4% | 10.4% |
| 净利润同比 | 4.7% | 11.8% |
| 每股收益（稀释后） | — | $0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FONRRVSB
| Q4 25 | $25.5M | $14.0M | ||
| Q3 25 | $26.0M | $13.6M | ||
| Q2 25 | $27.3M | $13.3M | ||
| Q1 25 | $27.2M | $12.9M | ||
| Q4 24 | $24.9M | $12.7M | ||
| Q3 24 | $25.0M | $12.8M | ||
| Q2 24 | $25.9M | $12.2M | ||
| Q1 24 | $25.7M | $9.0M |
净利润FONRRVSB
| Q4 25 | $2.1M | $1.4M | ||
| Q3 25 | $2.3M | $1.1M | ||
| Q2 25 | $729.3K | $1.2M | ||
| Q1 25 | $2.5M | $1.1M | ||
| Q4 24 | $2.0M | $1.2M | ||
| Q3 24 | $3.1M | $1.6M | ||
| Q2 24 | $830.4K | $966.0K | ||
| Q1 24 | $1.9M | $-3.0M |
营业利润率FONRRVSB
| Q4 25 | 13.5% | 12.4% | ||
| Q3 25 | 14.1% | 10.2% | ||
| Q2 25 | 5.3% | 11.7% | ||
| Q1 25 | 15.2% | 11.3% | ||
| Q4 24 | 11.9% | 12.4% | ||
| Q3 24 | 21.0% | 15.5% | ||
| Q2 24 | 7.4% | 10.0% | ||
| Q1 24 | 16.8% | -47.5% |
净利率FONRRVSB
| Q4 25 | 8.0% | 9.8% | ||
| Q3 25 | 8.7% | 8.1% | ||
| Q2 25 | 2.7% | 9.2% | ||
| Q1 25 | 9.2% | 8.9% | ||
| Q4 24 | 7.9% | 9.7% | ||
| Q3 24 | 12.6% | 12.2% | ||
| Q2 24 | 3.2% | 7.9% | ||
| Q1 24 | 7.3% | -34.7% |
每股收益（稀释后）FONRRVSB
| Q4 25 | — | $0.07 | ||
| Q3 25 | — | $0.05 | ||
| Q2 25 | — | $0.06 | ||
| Q1 25 | — | $0.05 | ||
| Q4 24 | — | $0.06 | ||
| Q3 24 | — | $0.07 | ||
| Q2 24 | — | $0.05 | ||
| Q1 24 | — | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $121.0K | $28.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $176.9M | $164.2M |
| 总资产 | $217.2M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FONRRVSB
| Q4 25 | $121.0K | $28.6M | ||
| Q3 25 | $122.0K | $32.8M | ||
| Q2 25 | $56.5M | $34.2M | ||
| Q1 25 | $123.0K | $29.4M | ||
| Q4 24 | $121.0K | $25.3M | ||
| Q3 24 | $136.0K | $31.0M | ||
| Q2 24 | $56.5M | $27.8M | ||
| Q1 24 | $134.0K | $23.6M |
总债务FONRRVSB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $66.9K | — | ||
| Q1 24 | — | — |
股东权益FONRRVSB
| Q4 25 | $176.9M | $164.2M | ||
| Q3 25 | $174.9M | $163.5M | ||
| Q2 25 | $172.6M | $162.0M | ||
| Q1 25 | $171.9M | $160.0M | ||
| Q4 24 | $169.8M | $158.3M | ||
| Q3 24 | $168.7M | $160.8M | ||
| Q2 24 | $166.0M | $155.9M | ||
| Q1 24 | $165.8M | $155.6M |
总资产FONRRVSB
| Q4 25 | $217.2M | $1.5B | ||
| Q3 25 | $218.4M | $1.5B | ||
| Q2 25 | $216.9M | $1.5B | ||
| Q1 25 | $214.9M | $1.5B | ||
| Q4 24 | $208.0M | $1.5B | ||
| Q3 24 | $212.3M | $1.5B | ||
| Q2 24 | $214.2M | $1.5B | ||
| Q1 24 | $209.6M | $1.5B |
负债/权益比FONRRVSB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $171.0K | $-506.0K |
| 自由现金流经营现金流 - 资本支出 | $-227.0K | $-736.0K |
| 自由现金流率自由现金流/营收 | -0.9% | -5.2% |
| 资本支出强度资本支出/营收 | 1.6% | 1.6% |
| 现金转化率经营现金流/净利润 | 0.08× | -0.37× |
| 过去12个月自由现金流最近4个季度 | $5.7M | $20.4M |
8季度趋势，按日历期对齐
经营现金流FONRRVSB
| Q4 25 | $171.0K | $-506.0K | ||
| Q3 25 | $1.7M | $16.8M | ||
| Q2 25 | $4.2M | $-697.0K | ||
| Q1 25 | $3.1M | $8.3M | ||
| Q4 24 | $2.2M | $2.2M | ||
| Q3 24 | $1.7M | $764.0K | ||
| Q2 24 | $4.6M | $5.4M | ||
| Q1 24 | $2.8M | $12.8M |
自由现金流FONRRVSB
| Q4 25 | $-227.0K | $-736.0K | ||
| Q3 25 | $-177.0K | $16.4M | ||
| Q2 25 | $3.6M | $-773.0K | ||
| Q1 25 | $2.6M | $5.6M | ||
| Q4 24 | $1.5M | $1.9M | ||
| Q3 24 | $-148.0K | $-1.4M | ||
| Q2 24 | $4.2M | $5.3M | ||
| Q1 24 | $2.6M | $7.1M |
自由现金流率FONRRVSB
| Q4 25 | -0.9% | -5.2% | ||
| Q3 25 | -0.7% | 120.1% | ||
| Q2 25 | 13.1% | -5.8% | ||
| Q1 25 | 9.4% | 43.1% | ||
| Q4 24 | 6.0% | 15.0% | ||
| Q3 24 | -0.6% | -11.3% | ||
| Q2 24 | 16.1% | 43.7% | ||
| Q1 24 | 10.2% | 79.0% |
资本支出强度FONRRVSB
| Q4 25 | 1.6% | 1.6% | ||
| Q3 25 | 7.2% | 2.9% | ||
| Q2 25 | 2.4% | 0.6% | ||
| Q1 25 | 2.2% | 21.0% | ||
| Q4 24 | 3.0% | 2.4% | ||
| Q3 24 | 7.2% | 17.3% | ||
| Q2 24 | 1.6% | 0.9% | ||
| Q1 24 | 0.7% | 62.0% |
现金转化率FONRRVSB
| Q4 25 | 0.08× | -0.37× | ||
| Q3 25 | 0.75× | 15.25× | ||
| Q2 25 | 5.79× | -0.57× | ||
| Q1 25 | 1.26× | 7.20× | ||
| Q4 24 | 1.14× | 1.79× | ||
| Q3 24 | 0.53× | 0.49× | ||
| Q2 24 | 5.54× | 5.63× | ||
| Q1 24 | 1.50× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FONR
| Managementof Diagnostic Imaging Centers | $23.2M | 91% |
| Manufacturingand Servicingof Medical Equipment | $2.4M | 9% |
RVSB
暂无分部数据
